ArticleAntimicrobial agents and chemotherapy2009

Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

Valentina Svicher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.